Provention Bio Inc (PRVB)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
24.98 +0.75 (+3.10%) 04/26/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 24.98 unch (unch) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -113,565 | -114,432 | -98,581 | -43,285 | -26,478 |
| Depreciation Amortization | 1,265 | 925 | 280 | -16 | N/A |
| Accounts receivable | -1,359 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,215 | -4,022 | 5,793 | 1,207 | 109 |
| Other Working Capital | 17,937 | 6,320 | 8,717 | 4,394 | -1,803 |
| Other Operating Activity | 17,099 | 15,824 | 7,455 | 1,635 | 5,530 |
| Operating Cash Flow | $-75,408 | $-95,385 | $-76,336 | $-36,065 | $-22,642 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -103,082 | -55,285 | -28,715 | -46,250 | N/A |
| PPE Investments | -795 | -961 | -1,111 | N/A | N/A |
| Purchase Of Investment | 30,750 | 25,150 | 55,000 | N/A | N/A |
| Other Investing Activity | -15,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-88,127 | $-31,096 | $25,174 | $-46,250 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 23,709 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 48,451 | 102,377 | 114,291 | 42,941 | 59,347 |
| Other Financing Activity | 57,224 | 0 | 0 | 20,000 | 0 |
| Financing Cash Flow | $129,384 | $102,377 | $114,291 | $62,941 | $59,347 |
| Beginning Cash Position | 78,190 | 102,294 | 39,165 | 58,539 | 21,834 |
| End Cash Position | 44,039 | 78,190 | 102,294 | 39,165 | 58,539 |
| Net Cash Flow | $-34,151 | $-24,104 | $63,129 | $-19,374 | $36,705 |
| Free Cash Flow | |||||
| Operating Cash Flow | -75,408 | -95,385 | -76,336 | -36,065 | -22,642 |
| Capital Expenditure | -795 | -961 | -1,111 | N/A | N/A |
| Free Cash Flow | -76,203 | -96,346 | -77,447 | -36,065 | -22,642 |